IL4 rs1800759: Understanding the Promoter Variant
The rs1800759 variant is a single nucleotide polymorphism located in the promoter region of the IL4 gene. It is studied for its potential role in modulating IL-4 transcription, which may influence total serum IgE levels and susceptibility to atopic conditions like asthma and dermatitis.
What each genotype means
Baseline IL-4 expression
This genotype represents the common ancestral form of the IL4 promoter region. Research suggests this version is associated with standard baseline levels of IL-4 transcription, though individual risk for atopic conditions remains complex and influenced by many other genetic and environmental factors.
This is the most common genotype in European populations, where the T allele is less frequent.
Potential increased IL-4 activity
Carrying one copy of the T allele may be associated with enhanced IL-4 transcription compared to the CC genotype. Some studies suggest this may correlate with higher total serum IgE levels and a modest increase in susceptibility to allergic asthma or atopic dermatitis, though findings are inconsistent across different ancestral groups.
This heterozygous genotype is common in many populations, particularly in groups where the T allele frequency reaches 0.50 or higher.
Elevated IL-4 expression profile
Individuals with this genotype carry two copies of the T allele, which has been linked in some research to increased IL-4 promoter activity. While this is statistically associated with higher IgE levels and increased risk for atopic conditions in certain studies, it is not a diagnostic marker and does not guarantee the development of any disease. Please discuss any concerns regarding allergic symptoms or asthma management with your clinician.
This genotype is more frequently observed in East Asian and African populations, where the T allele is more common, compared to European populations.
What is rs1800759?
The rs1800759 variant is a specific genetic change, often referred to as a -589C>T promoter polymorphism, situated within the IL4 gene. In genetics, a promoter is a region of DNA that initiates the transcription of a particular gene. By sitting in this regulatory area, the rs1800759 variant has the potential to alter how much of the IL-4 protein is produced by the body. Because IL-4 is a critical signaling molecule in the immune system, changes in its expression levels can theoretically impact how the body responds to allergens. Researchers identify this variant by its rsID (reference SNP cluster ID), which acts as a unique identifier in genomic databases. While it is frequently discussed in the context of immune-related traits, it is important to note that the presence of this variant does not guarantee the development of any specific health condition, as complex traits are influenced by a combination of many genetic factors and environmental exposures.
The Role of the IL4 Gene
The IL4 gene provides instructions for making a protein called interleukin-4. This protein is a cytokine, a type of signaling molecule that plays a central role in the immune system. Specifically, IL-4 is essential for the development and function of T-helper 2 (Th2) cells, which are involved in the body's response to parasites and allergens. When the immune system encounters an allergen, IL-4 helps trigger the production of immunoglobulin E (IgE) antibodies. Elevated levels of IgE are a hallmark of allergic responses, including those seen in asthma, eczema, and allergic rhinitis. Because IL-4 acts as a master regulator for these pathways, variations in the gene's promoter region—like rs1800759—are of significant interest to scientists investigating why some individuals are more prone to allergic inflammation than others. By studying how this variant affects IL-4 production, researchers hope to better understand the underlying biological mechanisms of atopic diseases.
Research and Evidence Strength
The association between rs1800759 and allergic traits is considered to have limited or mixed evidence. While some early studies suggested that the T allele might enhance IL-4 transcription and correlate with higher serum IgE levels or increased susceptibility to asthma and atopic dermatitis, findings have been inconsistent across different populations. Genetic research often faces challenges with replication; what is observed in one ethnic group may not be seen in another due to differences in linkage disequilibrium—the tendency of certain genetic markers to be inherited together. Furthermore, many studies have produced conflicting results, with some finding no significant link between this specific SNP and clinical outcomes. Because of these inconsistencies, the scientific community views the evidence for this variant as requiring further validation. It is not currently used as a definitive diagnostic tool, and it is best understood as one of many potential contributors to a complex, polygenic landscape rather than a single cause of disease.
What You Can Do With This Information
Understanding your genetic variants can be an educational experience, but it is important to maintain a realistic perspective on what this information means for your health. Genetic data regarding variants like rs1800759 is primarily used for research purposes and does not provide a medical diagnosis. If you have concerns about allergies, asthma, or skin conditions, the most effective approach is to consult with a healthcare professional, such as an allergist or immunologist. They can evaluate your symptoms, medical history, and environmental factors to provide appropriate care. Never use genetic information to make decisions about medications or treatments without consulting your clinician or pharmacist. If you are interested in how your genetics might influence your health, consider discussing these topics with a genetic counselor who can help interpret the significance of such findings within the context of your overall health and family history.
How common is this variant?
The minor allele (T) frequency is approximately 0.15–0.20 in European populations, while it can reach frequencies of 0.50–0.60 in certain East Asian and African groups.
Frequently asked questions
Does having the rs1800759 variant mean I have asthma?
No. Having a specific genotype at this location does not mean you have or will develop asthma. Asthma is a complex condition influenced by many genes and environmental factors.
Can I use this SNP to predict my allergy risk?
Currently, this SNP is not used for clinical risk prediction. The evidence linking it to allergic traits is inconsistent, and it cannot reliably predict individual health outcomes.
Is rs1800759 the same as rs2243250?
In many scientific publications, rs1800759 and rs2243250 are used to refer to the same promoter polymorphism in the IL4 gene. Always check the specific genomic coordinates if you are unsure.
Should I change my medication based on my genotype?
No. You should never change your medication or treatment plan based on genetic test results without first consulting your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800759?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL4
An intronic IL4 variant associated with heightened susceptibility to beta-lactam and penicillin immediate allergic reactions.
Variant within the IL4 gene region significantly associated with risk of penicillin hypersensitivity and immediate allergic reactions.
Intron-1 polymorphism in IL4; studies on its association with IgE levels and allergy susceptibility have yielded inconsistent results across populations.
Promoter variant (C-590T) in IL4; while historically linked to IgE production and asthma, findings remain inconsistent across diverse ethnic populations.
Located in the Th2 cytokine locus between IL4 and KIF3A, this variant is robustly associated with overall food allergy risk independent of atopic dermatitis status.